Precision System Science Co Ltd
Precision System Science Co Ltd designs and develops advanced medical equipment and technology, primarily serving the healthcare sector through specialized diagnostic and therapeutic solutions.
Business. Precision System Science Co Ltd (7707.T) is a Japanese company engaged in the Advanced Medical Equipment & Technology industry within the Healthcare Services & Equipment sector. The firm primarily operates through a product-sale revenue model, focusing on the development and distribution of medical devices and related technologies. Headquartered in Japan, the company is listed on the Tokyo Stock Exchange. Specific details regarding operating segments and geographic revenue breakdowns are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Precision System Science Co Ltd (7707.T) is a Japanese company engaged in the Advanced Medical Equipment & Technology industry within the Healthcare Services & Equipment sector. The firm primarily operates through a product-sale revenue model, focusing on the development and distribution of medical devices and related technologies. Headquartered in Japan, the company is listed on the Tokyo Stock Exchange. Specific details regarding operating segments and geographic revenue breakdowns are not available.
Precision System Science Co Ltd maintains a strong liquidity position, with cash and equivalents amounting to ¥20,496,960,000, which significantly exceeds its total liabilities of ¥2,177,686,000. The company's debt-to-equity ratio of 0.31 indicates a conservative capital structure, and its current ratio of 2.66 suggests a solid ability to meet short-term obligations.
The company's profitability metrics, including a return on equity of 1.52% and a return on assets of 1.03%, are below the typical thresholds for high-growth or high-margin industries. These figures suggest that the company is generating modest returns relative to its equity and asset base.
Precision System Science Co Ltd operates in a single business segment focused on advanced medical equipment and technology. Its geographic exposure is not disclosed in the available data, but the company's revenue concentration in one segment implies that its performance is closely tied to the healthcare equipment market.
The company's growth trajectory is not explicitly outlined in the available data, but its current financial performance suggests a stable, rather than rapidly growing, business. The absence of significant revenue or earnings growth in the most recent period indicates a need for further analysis of its long-term growth potential.
The risk assessment for Precision System Science Co Ltd indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's conservative capital structure and strong cash reserves reduce the likelihood of near-term financial distress.
Recent financial filings and transcripts do not provide specific details on the company's strategic initiatives or operational changes. However, the absence of significant dilution or liquidity risks suggests that the company is maintaining a stable financial position.
- Precision System Science Co Ltd maintains a conservative capital structure with a low debt-to-equity ratio and strong liquidity.
- The company's profitability metrics are modest, indicating a need for improvement in returns on equity and assets.
- The company operates in a single business segment focused on advanced medical equipment and technology.
- There are no immediate liquidity or dilution risks, suggesting a stable financial position.
- The company's growth trajectory is not clearly defined in the available data, indicating a need for further analysis.
Bull / Bear case
Generated · model-assistedFree cash flow improved by 90.8% year-over-year, reaching a loss of only 68 million yen.
Long-term debt decreased to 564 million yen in FY2025, down from 1.37 billion yen in FY2024.
The company reported a net loss of 253 million yen in FY2025, continuing a trend of negative earnings.
Free cash flow remained negative at 68 million yen in FY2025, indicating ongoing cash burn.
Gross profit fell to 1.38 billion yen in FY2025, down from 3.1 billion yen in FY2021.
Return on assets of 1.0% suggests inefficient utilization of the company's asset base.
In focus — financials by report
Revenue ¥1.22B, +8,9% YoY; Operating income +142,3% YoY.
- ▍Revenue ¥1.22B, +8,9% YoY
- ▍Operating income +142,3% YoY
- ▍Net income +109,8% YoY
- ▍Net margin 0.6%
Revenue ¥1.32B, +22,1% YoY; Operating income +174,3% YoY.
- ▍Revenue ¥1.32B, +22,1% YoY
- ▍Operating income +174,3% YoY
- ▍Net income +168,4% YoY
- ▍Net margin 4.1%
Revenue ¥1.23B, +18,5% YoY; Operating income +86,2% YoY.
- ▍Revenue ¥1.23B, +18,5% YoY
- ▍Operating income +86,2% YoY
- ▍Net income +85,6% YoY
- ▍Net margin -5.4%
Revenue ¥1.26B, +36,1% YoY; Operating income −139,5% YoY.
- ▍Revenue ¥1.26B, +36,1% YoY
- ▍Operating income −139,5% YoY
- ▍Net income −143,1% YoY
- ▍Net margin -2.4%
Revenue ¥1.12B; Operating income -¥65.1M.
- ▍Revenue ¥1.12B
- ▍Operating income -¥65.1M
- ▍Net margin -6.8%
Revenue ¥1.08B; Operating income -¥72.1M.
- ▍Revenue ¥1.08B
- ▍Operating income -¥72.1M
- ▍Net margin -7.4%
Revenue ¥1.04B; Operating income -¥448.3M.
- ▍Revenue ¥1.04B
- ▍Operating income -¥448.3M
- ▍Net margin -44.6%
Revenue ¥929.1M; Operating income ¥77.2M.
- ▍Revenue ¥929.1M
- ▍Operating income ¥77.2M
- ▍Net margin 7.5%
Revenue ¥4.69B, +17,9% YoY; Operating income +78,0% YoY.
- ▍Revenue ¥4.69B, +17,9% YoY
- ▍Operating income +78,0% YoY
- ▍Net income +77,4% YoY
- ▍Free cash flow +90,8% YoY
- ▍Net margin -5.4%
Revenue ¥3.98B, −24,6% YoY; Operating income +16,1% YoY.
- ▍Revenue ¥3.98B, −24,6% YoY
- ▍Operating income +16,1% YoY
- ▍Net income +15,3% YoY
- ▍Free cash flow +12,2% YoY
- ▍Net margin -28.2%
Revenue ¥5.28B, −29,0% YoY; Operating income −970,7% YoY.
- ▍Revenue ¥5.28B, −29,0% YoY
- ▍Operating income −970,7% YoY
- ▍Net income −3 020,9% YoY
- ▍Free cash flow +53,6% YoY
- ▍Net margin -25.1%
Revenue ¥7.43B, −20,1% YoY; Operating income −84,0% YoY.
- ▍Revenue ¥7.43B, −20,1% YoY
- ▍Operating income −84,0% YoY
- ▍Net income −94,3% YoY
- ▍Free cash flow −181,4% YoY
- ▍Net margin 0.6%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Return On Assetsnet_income / total_assets
- Precision System Science Co Ltd Market data — financials · 2026-05-27
- Precision System Science Co Ltd Market data — analyst estimates · 2026-05-27